Neurocrine Biosciences, Inc. (NBIX)
NBIX price $141.41 -0.59 -0.41%
- Ticker
- NBIX
- Price
- $141.41
- Change
- -0.59 -0.41%
- Market cap
- $14.37B
- P/E
- 20.14
- Forward P/E
- 19.87
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 68
Neurocrine Biosciences, Inc. is a pharmaceutical firm dedicated to the creation, advancement, and commercialization of medicines addressing a spectrum of neurological, endocrine, and psychiatric conditions. Its current therapeutic pipeline and marketed products target disorders such as tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, alongside numerous experimental compounds in various…